SETMAR and thyroid gland carcinoma: In contrast, the knockdown of SETMAR in vitro significantly reduced the expression of differentiation markers in thyroid cancer cells (Figure 3B; Figure S2B, Supporting Information), increased proliferation (Figure 3D) and decreased radioactive iodine uptake (Figure 3F).